Richard Law
Stock Analyst at Goldman Sachs
(0)
# 4557
Out of 5,370 analysts
63
Total ratings
35.71%
Success rate
-12.23%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OLMA Olema Pharmaceutical... | Maintains: Buy | 20 18 | 4.17 | 331.65% | 5 | May 14, 2025 | |
RCKT Rocket Pharmaceutica... | Maintains: Neutral | 15 13 | 2.92 | 345.21% | 3 | May 9, 2025 | |
CLDX Celldex Therapeutics | Maintains: Neutral | 36 31 | 20.2 | 53.47% | 3 | May 9, 2025 | |
VRDN Viridian Therapeutic... | Maintains: Buy | 31 27 | 15.48 | 74.42% | 3 | May 7, 2025 | |
MLTX MoonLake | Maintains: Buy | 82 73 | 42.51 | 71.72% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 24 | 13.42 | 78.84% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 | 4.84 | 127.27% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 31 | 10.9 | 184.4% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 47 | 17.46 | 169.19% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 62 63 | 43.4 | 45.16% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 37 | 46.66 | -20.7% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 76 | 9.89 | 668.45% | 6 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 | n/a | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 14 | 2.42 | 478.51% | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 | 7.66 | 696.34% | 4 | May 8, 2023 |